Stenotrophomonas maltophilia are increasingly recognized as significant opportunistic pathogens in healthcare settings worldwide, the global spread of multidrug-resistant strains of this species being...

Shionogi & Co., Ltd. recently announced that the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee voted to recommend approval of the investigational antibiotic cefiderocol...